PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that 27 abstracts on the Company’s research in liver disease have been accepted for presentation at The Liver Meeting® 2012, the 63rd annual meeting of The American Association for the Study of Liver Diseases (AASLD), in Boston, November 9 – 13.
